Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem 278: 43430–43436. 33. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17: 181–190. 34. Nelson O, Tu H, Lei T, Bentahir M, de Strooper B, et al. (2007) Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. J Clin Invest 117: 1230–1239. 35. Heilig EA, Xia W, Shen J, Kelleher RJ (2010) A presenilin-1 mutation identified in familial Alzheimer’s disease with cotton wool plaques causes nearly complete loss of {gamma}-secretase activity. J Biol Chem. 36. Lichtenthaler SF, Multhaup G, Masters CL, Beyreuther K (1999) A novel substrate for analyzing Alzheimer’s disease gamma-secretase. FEBS letters 453: 288–292. 37. Fraering PC, LaVoie MJ, Ye W, Ostaszewski BL, Kimberly WT, et al. (2004) Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex. Biochemistry 43: 323–333. 38. Duff K, Eckman C, Zehr C, Yu X, Prada CM, et al. (1996) Increased amyloid- beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383: 710–713. 39. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, et al. (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13: 45–53. 40. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, et al. (1992) Assembly and aggregation properties of synthetic Alzheimer’s A4/beta amyloid peptide analogs. J Biol Chem 267: 546–554. 41. Jan A, Gokce O, Luthi-Carter R, Lashuel HA (2008) The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem 283: 28176–28189. 42. Jarrett JT, Berger EP, Lansbury PT, Jr. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease. Biochemistry 32: 4693–4697. 43. Scheuner D, Eckman C, Jensen M, Song X, Citron M, et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2: 864–870. 44. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97–100. 45. Borchelt DR, Lee MK, Gonzales V, Slunt HH, Ratovitski T, et al. (2002) Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice. Neurobiol Aging 23: 171–177. 46. Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, et al. (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7: 940–946. Purified c-Secretase Complexes with PS1 Mutations 47. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, et al. (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360: 672–674. 48. Haass C, Lemere CA, Capell A, Citron M, Seubert P, et al. (1995) The Swedish mutation causes early-onset Alzheimer’s disease by beta-secretase cleavage within the secretory pathway. Nat Med 1: 1291–1296. 49. Munter LM, Botev A, Richter L, Hildebrand PW, Althoff V, et al. (2010) Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. J Biol Chem 285: 21636–21643. 50. Citron M, Eckman CB, Diehl TS, Corcoran C, Ostaszewski BL, et al. (1998) Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein. Neurobiol Dis 5: 107–116. 51. Dumanchin C, Tournier I, Martin C, Didic M, Belliard S, et al. (2006) Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques. Hum Mutat 27: 1063. 52. Kumar-Singh S, Theuns J, Van Broeck B, Pirici D, Vennekens K, et al. (2006) Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat 27: 686–695. 53. Steiner H, Romig H, Grim MG, Philipp U, Pesold B, et al. (1999) The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J Biol Chem 274: 7615–7618. 54. Houlden H, Baker M, McGowan E, Lewis P, Hutton M, et al. (2000) Variant Alzheimer’s disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 48: 806–808. 55. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, et al. (2005) Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46: 541–554. 56. Veeraraghavalu K, Choi SH, Zhang X, Sisodia SS (2010) Presenilin 1 mutants impair the self-renewal and differentiation of adult murine subventricular zone- neuronal progenitors via cell-autonomous mechanisms involving notch signal- ing. J Neurosci 30: 6903–6915. 57. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, et al. (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42: 23–36. 58. Wolfe MS (2012) gamma-Secretase inhibitors and modulators for Alzheimer’s disease. Journal of neurochemistry 120 Suppl 1: 89–98. 59. Schor NF (2011) What the halted phase III gamma-secretase inhibitor trial may (or may not) be telling us. Annals of neurology 69: 237–239. 60. Xu X (2009) Gamma-secretase catalyzes sequential cleavages of the AbetaPP transmembrane domain. Journal of Alzheimer’s disease : JAD 16: 211–224. 61. Salmon P, Trono D (2007) Production and titration of lentiviral vectors. Curr Protoc Hum Genet Chapter 12: Unit 12 10. PLoS ONE | www.plosone.org 13 April 2012 | Volume 7 | Issue 4 | e35133